Eli Lilly and Company
LLY
$1,105.00
-$21.80-1.94%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.63% | 9.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.63% | 9.61% | |||
| Cost of Revenue | 6.09% | 12.08% | |||
| Gross Profit | 1.90% | 9.10% | |||
| SG&A Expenses | -15.14% | 31.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.74% | 16.81% | |||
| Operating Income | 12.89% | 1.90% | |||
| Income Before Tax | 7.06% | 14.29% | |||
| Income Tax Expenses | -10.72% | -1.30% | |||
| Earnings from Continuing Operations | 11.42% | 18.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.42% | 18.90% | |||
| EBIT | 12.89% | 1.90% | |||
| EBITDA | 11.25% | 3.09% | |||
| EPS Basic | 11.86% | 18.76% | |||
| Normalized Basic EPS | 9.65% | 8.24% | |||
| EPS Diluted | 11.75% | 19.03% | |||
| Normalized Diluted EPS | 9.47% | 8.47% | |||
| Average Basic Shares Outstanding | -0.39% | 0.12% | |||
| Average Diluted Shares Outstanding | -0.23% | -0.09% | |||
| Dividend Per Share | 15.33% | 0.00% | |||
| Payout Ratio | 0.03% | -0.16% | |||